Trends in organ donor management: 2002 to 2012

Area of Science:

• Transplantation immunology
• Organ donor management
• Endocrinology

Background:

• Advancements in donor management have improved graft quantity and quality.
• Hormone replacement therapy (HRT) is increasingly used in brain-dead donors.
• The study investigates the impact of HRT on organ donation outcomes.

Purpose of the Study:

• To determine the association between increased hormone replacement therapy (HRT) use and organ donation outcomes.
• To analyze trends in donor characteristics, organ recovery, and transplant wait times.
• To evaluate the effectiveness of HRT in optimizing organ availability.

Main Methods:

• Analysis of the Organ Procurement and Transplant Network donor database (2001-2012).
• Identification of hormone replacement therapy (HRT) via thyroid hormone infusion.
• Definition of expanded criteria donors (age ≥ 60 years) and calculation of HRT incidence, donor, and organ recovery rates.

Main Results:

• Hormone replacement therapy (HRT) use rose from 25.6% to 72.3% of brain-dead donors.
• Overall donor and organ numbers increased significantly, but high-yield donor rates decreased.
• Thoracic transplant recipient wait times decreased substantially (462.2 to 170.4 days).

Conclusions:

• Increased hormone replacement therapy (HRT) use in brain-dead donors correlates with greater overall organ availability.
• HRT may facilitate the utilization of previously unsuitable donors.
• The findings suggest HRT is a valuable strategy for enhancing organ recovery and transplantation.